Health · 6 views
Sustained clinical responses seen with neuroimmune modulation for rheumatoid arthritis
Twenty-four-month data show sustained clinical responses for patients receiving neuroimmune modulation therapy for rheumatoid arthritis (RA), according to a study presented at the annual meeting of the American College of Rheumatology…
Summary
Twenty-four-month data show sustained clinical responses for patients receiving neuroimmune modulation therapy for rheumatoid arthritis (RA), according to a study presented at the annual meeting of the American College of Rheumatology , held from Nov. 6 to 11 in Orlando, Florida. John Tesser, M.D., from Arizona Arthritis & Rheumatology Associates in Phoenix, and colleagues reported long-term safety and efficacy outcomes at 24 months in a randomized pivotal trial.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Women's health research highlights the role of molecular testing in precision medicineContinue reading
- STAT+: Senators introduce bill to curb conflicts of interest on preventive care panelContinue reading
- Microsoft outage hits hospitals, GPs, schools and police across UKContinue reading
- Mobile app and telemonitoring improve quality of life and symptoms in patients with heart failureContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow